ðŠ ææ¥å€æ¥ã®ç©ºæ°ãããŠã€ã«ã¹ãæ€åºïŒæ£è ã®ææç¶æ³ãšã®æå€ãªé¢é£æ§ãšã¯ïŒ
ææ¥å€æ¥ã¯ãæ§ã ãªç æ°ãæªæãæ±ããæ£è ããã蚪ããå Žæã§ãããç¹ã«åŒåžåšææçã®æ£è ãããéäžããããç°å¢ã§ãããã®ãããææçã®æµè¡ç¶æ³ãææ¡ããäžã§éåžžã«éèŠãªæ ç¹ãšãªããŸãããããŸã§ãææ¥å€æ¥ã§ã®ææçã®ç£èŠã¯ãäž»ã«æ£è ããã®çç¶ãèšåºæ€æ»ã®çµæã«åºã¥ããŠè¡ãããŠããŸããã
ãããããã空æ°äžã®ãŠã€ã«ã¹ã調ã¹ãããšã§ãããæ©ããåºç¯å²ã«ãããææçã®æµè¡ãå¯ç¥ã§ãããšãããã©ãã§ããããïŒ ä»åã玹ä»ããç ç©¶ã¯ãææ¥å€æ¥ã®åŸ å宀ã®ç©ºæ°äžã«ååšããåŒåžåšãŠã€ã«ã¹ãšãå®éã«å蚺ããæ£è ããã®ãŠã€ã«ã¹ææç¶æ³ãšã®éã«ãã©ã®ãããªé¢é£ãããã®ãã調ã¹ãç»æçãªãã®ã§ãã
ð¬ ç ç©¶ã®èæ¯ãšç®çïŒç©ºæ°ãµã³ããªã³ã°ã®å¯èœæ§ãæ¢ã
ææ¥å€æ¥ïŒED: Emergency DepartmentïŒâ»ç·æ¥æ§ã®é«ãç æ°ãæªæã®æ£è ã24æéäœå¶ã§åãå ¥ããå»çæ©é¢ã®éšçœ²ã¯ãåŒåžåšãŠã€ã«ã¹â»é¢šéªãã€ã³ãã«ãšã³ã¶ãæ°åã³ãããŠã€ã«ã¹ãªã©ãäž»ã«åŒåžåšç³»ã«ææãããŠã€ã«ã¹ã®ç·ç§°ã®ç£èŠã«ãããŠéèŠãªæ ç¹ã§ããå€ãã®æ£è ãããéãŸããããææçãåºããããããªã¹ã¯ãæ±ããŠããŸãããããŸã§ã®ãŠã€ã«ã¹ç£èŠã¯ãäž»ã«æ£è ããå人ã®èšåºæ€æ»â»å»çæ©é¢ã§è¡ããããæ£è ããæ¡åããæ€äœïŒéŒ»åœé ã¬ããæ¶²ãªã©ïŒãçšããŠãŠã€ã«ã¹ææã®æç¡ã調ã¹ãæ€æ»ã«äŸåããŠããŸããããç°å¢äžã®ãŠã€ã«ã¹ãçŽæ¥æ€åºããã空æ°ãµã³ããªã³ã°â»ç©ºæ°äžã®åŸ®ç²åã埮çç©ïŒãŠã€ã«ã¹ãªã©ïŒãæ¡åããåæããææ³ãã¯ããã®ç°å¢ã§ã¯ååã«æ€èšãããŠããŸããã§ããã
æ¬ç ç©¶ã®ç®çã¯ãææ¥å€æ¥ã®åŸ å宀ã§ç©ºæ°ãµã³ããªã³ã°ãè¡ãã空æ°äžããæ€åºãããåŒåžåšãŠã€ã«ã¹ïŒCOVID-19â»æ°åã³ãããŠã€ã«ã¹ææçãã€ã³ãã«ãšã³ã¶Aâ»ã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹Aåã«ããææçãRSVâ»ããåŒåžåšåèäœãŠã€ã«ã¹ã乳幌å ã«éçãªåŒåžåšææçãåŒãèµ·ããããšãããïŒã®æ€åºç¶æ³ããåææã«ææ¥å€æ¥ãå蚺ããæ£è ããã®èšåºãŠã€ã«ã¹æ€æ»ã®çµæãšã©ã®ããã«é¢é£ããŠããããæããã«ããããšã§ãããããã«ããã空æ°ãµã³ããªã³ã°ãææçã®æ©æèŠæã·ã¹ãã ãšããŠåœ¹ç«ã€å¯èœæ§ãæ¢ããŸãã
𧪠ç ç©¶ã®æ¹æ³ïŒææ¥å€æ¥ã®åŸ å宀ã§ç©ºæ°äžã®ãŠã€ã«ã¹ãæ¡å
ãã®ç ç©¶ã§ã¯ãææ¥å€æ¥ã®åŸ å宀ãšãããå€ãã®äººãè¡ã亀ãå Žæã察象ã«ããŸãããç ç©¶è ãã¡ã¯ãç¹å®ã®æéã«ããã£ãŠåŸ å宀ã®ç©ºæ°ã宿çã«æ¡åããã空æ°ãµã³ããªã³ã°ãã宿œããŸããããã®ãµã³ããªã³ã°ã«ãã£ãŠã空æ°äžã«æµ®éãããŠã€ã«ã¹ç²åãåéããŸããã
åæã«ãåãæéã«ææ¥å€æ¥ãå蚺ããåŒåžåšææçã®çç¶ããã£ãæ£è ããã«å¯ŸããŠãéåžžã®èšåºãŠã€ã«ã¹æ€æ»ãè¡ããŸãããæ€æ»ã®å¯Ÿè±¡ãšãªã£ããŠã€ã«ã¹ã¯ãçŸåšãäžççã«æžå¿µãããŠããCOVID-19ãæ¯å¹Žæµè¡ããã€ã³ãã«ãšã³ã¶AããããŠä¹³å¹Œå ãäžå¿ã«éçåããããRSVã®3çš®é¡ã§ãã
ç ç©¶è ãã¡ã¯ã空æ°ãµã³ããªã³ã°ã§æ€åºããããŠã€ã«ã¹ã®çš®é¡ãšéããããŠæ£è ããã®èšåºæ€æ»ã§éœæ§ãšãªã£ããŠã€ã«ã¹ã®çš®é¡ãšæ°ãæ¯èŒããäž¡è ã®éã«çµ±èšåŠçã«æå³ã®ããé¢é£æ§ïŒææãªé¢é£â»çµ±èšåŠçã«å¶ç¶ã§ã¯ãªããšå€æãããã»ã©ãäºã€ã®äºæã®éã«æç¢ºãªé¢ä¿æ§ãããããšïŒããããã©ããã詳现ã«åæããŸããã
ð äž»ãªç ç©¶çµæïŒç©ºæ°äžã®ãŠã€ã«ã¹æ€åºãšæ£è ã®ææç¶æ³ã«ãææãªé¢é£ã
æ¬ç ç©¶ã§ã¯ãææ¥å€æ¥ã®åŸ å宀ã«ããã空æ°ãµã³ããªã³ã°ã§æ€åºãããåŒåžåšãŠã€ã«ã¹ãšãåææã«å蚺ããæ£è ããã®èšåºãŠã€ã«ã¹æ€æ»çµæãšã®éã«ãæç¢ºãªé¢é£æ§ãèªããããŸãããå ·äœçã«ã¯ã以äžã®ãŠã€ã«ã¹ã«ãããŠææãªé¢é£ã確èªãããŠããŸãã
| ãŠã€ã«ã¹çš®é¡ | 空æ°äžæ€åºãšèšåºæ€æ»çµæã®é¢é£æ§ | 詳现 |
|---|---|---|
| COVID-19 | ææãªé¢é£ãã | åŸ å宀ã®ç©ºæ°äžã§COVID-19ãŠã€ã«ã¹ãæ€åºããããšãåææã«ææ¥å€æ¥ãå蚺ããæ£è ããã®éã§COVID-19ã®éœæ§è ãå¢å ããåŸåãèŠãããŸããã |
| ã€ã³ãã«ãšã³ã¶A | ææãªé¢é£ãã | 空æ°äžã®ã€ã³ãã«ãšã³ã¶AãŠã€ã«ã¹æ€åºéãå€ãææã«ã¯ãæ£è ããã®ã€ã³ãã«ãšã³ã¶Aææè æ°ãå¢å ããããšã確èªãããŸããã |
| RSV | ææãªé¢é£ãã | RSVã«ã€ããŠãåæ§ã«ãåŸ å宀ã®ç©ºæ°äžã§ã®æ€åºãšãæ£è ããã®RSVææãšã®éã«çµ±èšçã«æå³ã®ããé¢é£ãèªããããŸããã |
ãã®çµæã¯ãææ¥å€æ¥ã®åŸ å宀ã®ç©ºæ°ã調ã¹ãããšã§ããã®å°åãæœèšã«ãããåŒåžåšãŠã€ã«ã¹ã®æµè¡ç¶æ³ããæ£è ããã®èšåºæ€æ»çµæãšé£åããŠææ¡ã§ããå¯èœæ§ã瀺åããŠããŸããã€ãŸãã空æ°äžã®ãŠã€ã«ã¹æ€åºããææçæµè¡ã®ãæ©æèŠæä¿¡å·ããšããŠæ©èœãããããããªããšããããšã§ãã
ð¡ ç ç©¶çµæã®èå¯ïŒç©ºæ°ãµã³ããªã³ã°ãç€ºãæªæ¥ã®ææç察ç
ä»åã®ç ç©¶ã§ãææ¥å€æ¥ã®åŸ å宀ã®ç©ºæ°äžããæ€åºãããCOVID-19ãã€ã³ãã«ãšã³ã¶AãRSVãšãã£ãåŒåžåšãŠã€ã«ã¹ããå®éã«ãã®æœèšãå蚺ããæ£è ããã®èšåºãŠã€ã«ã¹æ€æ»çµæãšææã«é¢é£ããŠããããšãæããã«ãªããŸãããããã¯ã空æ°ãµã³ããªã³ã°ãææç察çã«ãããŠéåžžã«ææãªããŒã«ã§ããããšã瀺åããŠããŸãã
ãã®çµæãããããã€ãã®éèŠãªèå¯ãå°ãåºãããŸãã
- æ©æèŠæã·ã¹ãã ãšããŠã®å¯èœæ§ïŒ 空æ°äžã®ãŠã€ã«ã¹æ€åºã¯ãæ£è ãããçç¶ã蚎ããŠå蚺ãããããæ©ããå°åã®ææç¶æ³ã®å€åãæããããšãã§ãããããããŸãããããã«ãããå»çæ©é¢ãå ¬è¡è¡çåœå±ã¯ãæµè¡ã®å åãæ©æã«å¯ç¥ããå¿ èŠãªå¯ŸçïŒäŸãã°ãç åºã®ç¢ºä¿ãå»çåŸäºè ã®é 眮ãã¯ã¯ãã³ã®æšå¥šãªã©ïŒãè¿ éã«è¬ããããšãå¯èœã«ãªããŸãã
- ææãªã¹ã¯ã®é«ãå Žæã®ç¹å®ïŒ ææ¥å€æ¥ã®ãããªãå€ãã®äººãéãŸãéé空éã§ã¯ãç©ºæ°ææã®ãªã¹ã¯ãé«ãŸããŸãã空æ°ãµã³ããªã³ã°ã«ãã£ãŠç¹å®ã®ãŠã€ã«ã¹ãæ€åºãããå Žåããã®ç©ºéã®ææ°ç¶æ³ãç©ºæ°æž æµå¯Ÿçãé©åã§ããããèŠçŽããã£ãããšãªããŸãã
- ç°å¢å¯Ÿçã®è©äŸ¡ïŒ ææ°ã·ã¹ãã ã®æ¹åã髿§èœãªç©ºæ°æž æµæ©ã®å°å ¥ãªã©ãç°å¢å¯Ÿçã®å¹æãè©äŸ¡ããææšãšããŠã空æ°ãµã³ããªã³ã°ã¯æå¹ã§ãã察çååŸã®ãŠã€ã«ã¹æ€åºéã®å€åãæ¯èŒããããšã§ããã®å¹æã客芳çã«æž¬å®ã§ããŸãã
- å ¬è¡è¡çãžã®è²¢ç®ïŒ å°åå šäœã®ææçãµãŒãã€ã©ã³ã¹â»ææçã®çºçç¶æ³ãç¶ç¶çã«ç£èŠã»èª¿æ»ããããšã«ãããŠãç é¢ã®ç©ºæ°ãµã³ããªã³ã°ããŒã¿ã掻çšããããšã§ãããå æ¬çãã€ãªã¢ã«ã¿ã€ã ãªæ å ±æäŸãå¯èœãšãªããåžæ°ãžã®æ³šæåèµ·ãè¡åå€å®¹ãä¿ãäžã§ã圹ç«ã€ã§ãããã
ãã®ç ç©¶ã¯ã空æ°äžã®ãŠã€ã«ã¹ããèŠããåãããããšã§ãææç察çã®æ°ããªã¢ãããŒããæäŸãããã®ãšèšããŸããç¹ã«ãçç¶ãåºã«ããæœäŒæéäžã®ææè ããç¡çç¶ã®ææè ããã®ãŠã€ã«ã¹æåºãæããããå¯èœæ§ããããããåŸæ¥ã®ç£èŠæ¹æ³ãè£å®ãããã匷åºãªææç察çãããã¯ãŒã¯ãæ§ç¯ããäžã§å€§ããªäžæ©ãšãªãã§ãããã
ð€ å®ç掻ãžã®ã¢ããã€ã¹ïŒç©ºæ°äžã®ãŠã€ã«ã¹ãã身ãå®ãããã«
ä»åã®ç ç©¶çµæã¯ã空æ°äžã®ãŠã€ã«ã¹ãç§ãã¡ã®å¥åº·ã«åœ±é¿ãäžããå¯èœæ§ã瀺åããŠããŸããã§ã¯ãç§ãã¡ã¯æ¥ã ã®ç掻ã®äžã§ãã©ã®ããã«ããŠç©ºæ°äžã®ãŠã€ã«ã¹ãã身ãå®ãã°è¯ãã®ã§ããããã以äžã«ãå®ç掻ã§å®è·µã§ããå ·äœçãªã¢ããã€ã¹ããŸãšããŸããã
- é©åãªãã¹ã¯ã®ççšïŒ ç¹ã«äººæ··ã¿ãå»çæ©é¢ãªã©ãææãªã¹ã¯ãé«ãå Žæã§ã¯ãäžç¹åžãã¹ã¯ãæ£ããççšããŸãããããã¹ã¯ã¯ããŠã€ã«ã¹ãå«ã飿²«ã®åžå ¥ã»æåºãé²ã广ããããŸãã
- ããŸããªææŽããšæææ¶æ¯ïŒ ãŠã€ã«ã¹ãä»çããæã§é¡ïŒç®ã錻ãå£ïŒãè§Šãããšã§ææããå¯èœæ§ããããŸããç³é¹žãšæ°Žã§äžå¯§ã«ææŽããããããã¢ã«ã³ãŒã«æ¶æ¯æ¶²ã§ææãæž æœã«ä¿ã¡ãŸãããã
- ææ°ã®åŸ¹åºïŒ 宀å ã§ã¯å®æçã«çªãéãããªã©ããŠææ°ãè¡ãã空æ°ã®å ¥ãæ¿ããä¿ããŸããããç¹ã«ã人ãå€ãéãŸãå Žæãéãåã£ã空éã§ã¯ãææ°æã®äœ¿çšãç©ºæ°æž æµæ©ã®æŽ»çšãæå¹ã§ãã
- äœèª¿ç®¡çãšå ç«ååäžïŒ ååãªç¡ç ããã©ã³ã¹ã®åããé£äºãé©åºŠãªéåãå¿ãããå ç«åãé«ããŸããããäœãå¥åº·ã§ããã°ããŠã€ã«ã¹ã«ææãã«ããããŸãææããŠãéçåãã«ããåŸåããããŸãã
- ã¯ã¯ãã³æ¥çš®ã®æ€èšïŒ ã€ã³ãã«ãšã³ã¶ãCOVID-19ãªã©ãå©çšå¯èœãªã¯ã¯ãã³ã¯ç©æ¥µçã«æ¥çš®ãæ€èšããŸããããã¯ã¯ãã³ã¯ãææçã®çºçãéçåãé²ãäžã§éåžžã«å¹æçã§ãã
- äœèª¿äžè¯æã®è¡åïŒ çºç±ãå³ãªã©ã®çç¶ãããå Žåã¯ãå€åºãæ§ããèªå® ã§éé€ããŸãããããããåŸãå€åºããå Žåã¯ããã¹ã¯ãççšããåšå²ãžã®é æ ®ãå¿ããªãã§ãã ãããå»çæ©é¢ãå蚺ããéã¯ãäºåã«é£çµ¡ããæç€ºã«åŸããŸãããã
- å ¬å ±æœèšã®å©çšæã®æ³šæïŒ ç é¢ã®åŸ å宀ãå ¬å ±äº€éæ©é¢ãªã©ãäžç¹å®å€æ°ã®äººãéãŸãå Žæã§ã¯ãç¹ã«ææå¯Ÿçãæèããé·æéã®æ»åšãé¿ãããªã©ã®å·¥å€«ãæå¹ã§ãã
ãããã®å¯Ÿçã¯ãäžã€äžã€ã¯åºæ¬çãªããšã§ãããç¶ç¶ããŠå®è·µããããšã§ã空æ°äžã®ãŠã€ã«ã¹ããç§ãã¡èªèº«ãšå€§åãªäººãå®ãããšã«ã€ãªãããŸãã
ð§ ç ç©¶ã®éçãšä»åŸã®èª²é¡ïŒãããªãç¥èŠãæ±ããŠ
ä»åã®ç ç©¶ã¯ãææ¥å€æ¥ã®ç©ºæ°äžã®ãŠã€ã«ã¹æ€åºãšæ£è ã®ææç¶æ³ãšã®éã«ææãªé¢é£ãããããšã瀺ããææç察çã«ããã空æ°ãµã³ããªã³ã°ã®å¯èœæ§ã倧ããåºããŸãããããããã©ã®ãããªç ç©¶ã«ãéçããããä»åŸã®èª²é¡ãååšããŸãã
- åäžæœèšã§ã®ç ç©¶ïŒ æ¬ç ç©¶ã¯ç¹å®ã®ææ¥å€æ¥ã§è¡ããããã®ã§ãããä»ã®å°åãç°ãªãèŠæš¡ã®å»çæ©é¢ã§ãåæ§ã®çµæãåŸããããã¯ããããªãæ€èšŒãå¿ èŠã§ããæœèšã®æ§é ãææ°ã·ã¹ãã ã®éããçµæã«åœ±é¿ãäžããå¯èœæ§ãèããããŸãã
- ãµã³ããªã³ã°æéãšé »åºŠïŒ ç ç©¶ãè¡ãããæéã空æ°ãµã³ããªã³ã°ã®é »åºŠãããŠã€ã«ã¹ã®æ€åºç¶æ³ã«åœ±é¿ãäžããå¯èœæ§ããããŸããããé·æéã«ãããç¶ç¶çãªãµã³ããªã³ã°ããç°ãªãå£ç¯ã§ã®ããŒã¿åéãæ±ããããŸãã
- ãŠã€ã«ã¹éãšææãªã¹ã¯ã®çŽæ¥çãªé¢é£ïŒ 空æ°äžã®ãŠã€ã«ã¹ãæ€åºããããšããŠãããããå®éã«ã©ã®çšåºŠã®ææãªã¹ã¯ã«ã€ãªããã®ãããã®éçãªé¢ä¿æ§ã«ã€ããŠã¯ããŸã æç¢ºãªçµè«ãåºãŠããŸããã空æ°äžã®ãŠã€ã«ã¹æ¿åºŠãšãå®éã«äººãææãã確çãšã®éã®çŽæ¥çãªé¢é£ãè§£æããããšããä»åŸã®éèŠãªèª²é¡ã§ãã
- ä»ã®åŒåžåšãŠã€ã«ã¹ãžã®é©çšïŒ ä»åã¯COVID-19ãã€ã³ãã«ãšã³ã¶AãRSVã«çŠç¹ãåœãŠãŸããããä»ã®åŒåžåšãŠã€ã«ã¹ïŒäŸãã°ãã¢ãããŠã€ã«ã¹ããã©ã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹ãªã©ïŒã«ã€ããŠãåæ§ã®é¢é£æ§ããããã©ããã®ç ç©¶ãå¿ èŠã§ãã
- ã³ã¹ããšå®çšæ§ïŒ 空æ°ãµã³ããªã³ã°ããã®åŸã®ãŠã€ã«ã¹åæã«ã¯ãã³ã¹ããšå°éçãªæè¡ãå¿ èŠã§ãããããæ¥åžžçãªææçç£èŠã·ã¹ãã ãšããŠåºãå°å ¥ããããã«ã¯ãããå¹ççã§ã³ã¹ãããã©ãŒãã³ã¹ã®é«ãæ¹æ³ã®éçºãæ±ããããŸãã
- ç°å¢èŠå ã®èæ ®ïŒ æ¹¿åºŠãæž©åºŠãææ°éãªã©ã空æ°äžã®ãŠã€ã«ã¹çåãæ¡æ£ã«åœ±é¿ãäžããæ§ã ãªç°å¢èŠå ã詳现ã«åæãããã®åœ±é¿ãèæ ®ããç ç©¶ãé²ããå¿ èŠããããŸãã
ãããã®èª²é¡ãå æããããå€ãã®ç¥èŠãç©ã¿éããããšã§ã空æ°ãµã³ããªã³ã°ã¯ææç察çã®åŒ·åãªæŠåšãšãªããç§ãã¡ã®å¥åº·ãšå®å šãå®ãäžã§äžå¯æ¬ ãªããŒã«ãšãªãã§ãããã
ãŸãšãïŒç©ºæ°äžã®ãŠã€ã«ã¹æ€åºãæããææç察çã®æ°ããªå°å¹³
ä»åã®ç ç©¶ã¯ãææ¥å€æ¥ã®åŸ å宀ãšããæ¥åžžçãªç°å¢ã®ç©ºæ°äžãããCOVID-19ãã€ã³ãã«ãšã³ã¶AãRSVãšãã£ãäž»èŠãªåŒåžåšãŠã€ã«ã¹ãæ€åºããããããå®éã«å蚺ããæ£è ããã®ãŠã€ã«ã¹ææç¶æ³ãšãææãªé¢é£ããããããšãæããã«ããŸããããã®çºèŠã¯ã空æ°ãµã³ããªã³ã°ãåãªãç°å¢ã¢ãã¿ãªã³ã°ã«ãšã©ãŸãããå°åã®ææçæµè¡ãæ©æã«å¯ç¥ããè¿ éãªå¯Ÿçãè¬ããããã®åŒ·åãªãæ©æèŠæã·ã¹ãã ããšããŠæ©èœããå¯èœæ§ã瀺ããŠããŸããç§ãã¡ã®èº«ã®åãã«ãã空æ°äžã®ãŠã€ã«ã¹ããèŠããåãããããšã§ãå»çæ©é¢ã¯ãã广çãªææå¶åŸ¡çãç«ãŠãå ¬è¡è¡çåœå±ã¯åžæ°ãžã®é©åãªæ å ±æäŸã泚æåèµ·ãè¡ãããšãã§ããããã«ãªããŸãããã®ç ç©¶ã¯ãææç察çã®æªæ¥ãèããäžã§ãéåžžã«éèŠãªäžæ©ãšãªãã§ããããç§ãã¡äžäººã²ãšãããææŽããææ°ããã¹ã¯ççšãšãã£ãåºæ¬çãªææå¯Ÿçãç¶ç¶ããããšã®éèŠæ§ãæ¹ããŠèªèããç§åŠçç¥èŠã«åºã¥ããæ°ããã¢ãããŒãããããå®å šã§å¥åº·ãªç€ŸäŒã®å®çŸã«è²¢ç®ããããšãæåŸ ããŸãã
é¢é£ãªã³ã¯é
- åœç«ææçç ç©¶æ
- åçåŽåç
- æ¥æ¬ææçåŠäŒ
- æ¥æ¬åŒåžåšåŠäŒ
- ç±³åœçŸç 察çäºé²ã»ã³ã¿ãŒïŒCDCïŒæ¥æ¬èªæ å ±
æžèªæ å ±
| DOI | 10.1017/ice.2026.10538 |
|---|---|
| PMID | 42839841 |
| PubMed URL | https://pubmed.ncbi.nlm.nih.gov/42839841/ |
| çºè¡å¹Ž | 2026 |
| èè å | Griffin Meggie, Ikenberry Helena, Gauger Joshua, Kuehnel Nicholas, Ellis Amy L, Machtinger Ari N, O'Connor David H, O'Connor Shelby L, Shirley Daniel, Pulia Michael S |
| èè æå± | BerbeeWalsh Department of Emergency Medicine, University of Wisconsin-Madison School of Medicine and Public Health, USA.; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison School of Medicine and Public Health, USA.; Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, USA. |
| éèªå | Infect Control Hosp Epidemiol |